H1N1 -Epidemiology Forecast to 2027

H1N1 -Epidemiology Forecast to 2027

Category

Pharmaceuticals

Published Date

1st Feb 2018

Pages

50

Choose License

Final Price

DelveInsight's "H1N1 (Swine Influenza) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the H1N1 (Swine Influenza) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027.

Markets Covered
• United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

Study Period: 2016-2027

H1N1 (Swine Influenza) Epidemiology
The epidemiology section covers the historical, current as well as forecasted epidemiology for H1N1 (Swine Influenza) in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders’ views are also taken into account to provide a deep understanding of the H1N1 (Swine Influenza) outlook. It also includes the explanation of changing trends of epidemiology outlining the H1N1 (Swine Influenza) scenario.

H1N1 (Swine Influenza) Epidemiology Segmentation
The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the H1N1 (Swine Influenza) thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope
• The report covers detailed overview of H1N1 (Swine Influenza) explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
• It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
• The H1N1 (Swine Influenza) Report assesses the disease risk and burden and highlights the unmet needs
• It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths
• 10 Year Forecast
• 7MM Coverage
• Total Cases in H1N1 (Swine Influenza)

Key assessments
• Patient Segmentation in H1N1 (Swine Influenza)
• H1N1 (Swine Influenza) Risk & Burden
• Factors driving growth in a specific H1N1 (Swine Influenza) patient population
1. Report Introduction
2. H1N1 (Swine Influenza) Epidemiology Overview at a Glance
2.1. Patient Share Distribution of H1N1 (Swine Influenza) in 2017
2.2. Patient Share Distribution of H1N1 (Swine Influenza) in 2027
3. Disease Background and Overview: H1N1 (Swine Influenza)
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of H1N1 (Swine Influenza) in 7MM
4.3. Total Prevalent/ Incident Patient Population of H1N1 (Swine Influenza) in 7MM – By Countries
5. Epidemiology of H1N1 (Swine Influenza) by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.1.3. Sub-Type Specific cases of the H1N1 (Swine Influenza) *
5.1.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.1.5. Diagnosed Cases of the H1N1 (Swine Influenza)
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.4.3. Sub-Type Specific cases of the H1N1 (Swine Influenza)*
5.4.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.4.5. Diagnosed Cases of the H1N1 (Swine Influenza)
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.5.3. Sub-Type Specific cases of the H1N1 (Swine Influenza)*
5.5.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.5.5. Diagnosed Cases of the H1N1 (Swine Influenza)
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.6.3. Sub-Type Specific cases of the H1N1 (Swine Influenza)*
5.6.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.6.5. Diagnosed Cases of the H1N1 (Swine Influenza)
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.7.3. Sub-Type Specific cases of the H1N1 (Swine Influenza)*
5.7.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.7.5. Diagnosed Cases of the H1N1 (Swine Influenza)
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.8.3. Sub-Type Specific cases of the H1N1 (Swine Influenza)*
5.8.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.8.5. Diagnosed Cases of the H1N1 (Swine Influenza)
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the H1N1 (Swine Influenza)
5.9.3. Sub-Type Specific cases of the H1N1 (Swine Influenza)*
5.9.4. Sex- Specific Cases of the H1N1 (Swine Influenza)*
5.9.5. Diagnosed Cases of the H1N1 (Swine Influenza)
6. Unmet Needs of the H1N1 (Swine Influenza)
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific
Table 1: Total Prevalent/Incident Cases of the H1N1 (Swine Influenza) in 7MM
Table 2: Total Prevalent/Incident Cases of the H1N1 (Swine Influenza) in 7MM by Countries
Table 3: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in United States (2016-2027)
Table 4: Sub-Type Specific cases of the H1N1 (Swine Influenza) in United States (2016-2027)*
Table 5: Sex- Specific Cases of the H1N1 (Swine Influenza) in United States (2016-2027)*
Table 6: Diagnosed Cases of the H1N1 (Swine Influenza) in United States (2016-2027)
Table 7: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in Germany (2016-2027)
Table 8: Sub-Type Specific cases of the H1N1 (Swine Influenza) in Germany (2016-2027) *
Table 9: Sex- Specific Cases of the H1N1 (Swine Influenza) in Germany (2016-2027) *
Table 10: Diagnosed Cases of the H1N1 (Swine Influenza) in Germany (2016-2027)
Table 11: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in France (2016-2027)
Table 12: Sub-Type Specific cases of the H1N1 (Swine Influenza) in France (2016-2027) *
Table 13: Sex- Specific Cases of the H1N1 (Swine Influenza) in France (2016-2027) *
Table 14: Diagnosed Cases of the H1N1 (Swine Influenza) in France (2016-2027)
Table 15: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in Italy (2016-2027)
Table 16: Sub-Type Specific cases of the H1N1 (Swine Influenza) in Italy (2016-2027) *
Table 17: Sex- Specific Cases of the H1N1 (Swine Influenza) in Italy (2016-2027) *
Table 18: Diagnosed Cases of the H1N1 (Swine Influenza) in Italy (2016-2027)
Table 19: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in Spain (2016-2027)
Table 20: Sub-Type Specific cases of the H1N1 (Swine Influenza) in Spain (2016-2027) *
Table 21: Sex- Specific Cases of the H1N1 (Swine Influenza) in Spain (2016-2027) *
Table 22: Diagnosed Cases of the H1N1 (Swine Influenza) in Spain (2016-2027)
Table 23: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in UK (2016-2027)
Table 24: Sub-Type Specific cases of the H1N1 (Swine Influenza) in UK (2016-2027) *
Table 25: Sex- Specific Cases of the H1N1 (Swine Influenza) in UK (2016-2027) *
Table 26: Diagnosed Cases of the H1N1 (Swine Influenza) in UK (2016-2027)
Table 27: Prevalent/Incident Cases of the H1N1 (Swine Influenza) in Japan (2016-2027)
Table 28: Sub-Type Specific cases of the H1N1 (Swine Influenza) in Japan (2016-2027) *
Table 29: Sex- Specific Cases of the H1N1 (Swine Influenza) in Japan (2016-2027) *
Table 30: Diagnosed Cases of the H1N1 (Swine Influenza) in Japan (2016-2027)

Get Free Sample

You can get a FREE sample of any report. Just click the "Free Sample" link.

Explore Latest Reports

If you have any special requirement or looking for more discounts, Kindly contact our sales team

Contact Us